U.S. health officials earlier in the week publicly rebuked the drugmaker for using "outdated information" when calculating that the vaccine was 79 per cent effective.

U.S. authorities said they were "concerned" about the information AstraZeneca provided from the trial, which initially claimed the COVID-19 vaccine is 79 per cent effective.